Sort
51,593 grants matching “hepatitis”
HIV CENTERS FOR UNDEREPRESENTED POPULATIONS IN RESEARCH CTU (HIV CURE CTU)
$2,642,740Stephen A Spector · University Of California, San Diego · UM1 · FY2014 · AI
Washington Metropolitan Women's Interagency HIV Study
$2,639,393Mary A Young · Georgetown University · U01 · FY2009 · AI
Subcutaneous Drug Development for Portal Hypertension Ascites
$2,638,464Gerardo M. Castillo · Pharmain Corporation · R44 · FY2025 · DK
Clinical Trials Network, Ohio Valley Node
$2,634,865Eugene C. Somoza · University Of Cincinnati · U10 · FY2007 · DA
DETECTION AND MODELS OF TOXICANT EXPOSURE
$2,634,787Robert H Tukey · University Of California, San Diego · P42 · FY2021 · ES
San Francisco Bay Clinical Trials Unit
$2,634,428Susan Buchbinder · Public Health Foundation Enterprises · UM1 · FY2019 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,632,704Andrea L Cox · Johns Hopkins University · U19 · FY2021 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,631,174Andrea L Cox · Johns Hopkins University · U19 · FY2022 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,630,987Andrea L Cox · Johns Hopkins University · U19 · FY2024 · AI
Mechanisms of spontaneous and vaccine mediated hepatitis C virus control to direct rational development of a novel HCV vaccine
$2,630,982Andrea L Cox · Johns Hopkins University · U19 · FY2023 · AI
Regulation of hepatic and systemic immune responses
$2,624,042Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Triglycerides, Diabetes and Cardiovascular Disease
$2,622,487Karin E. Bornfeldt · University Of Washington · P01 · FY2025 · HL
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,620,861Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$2,619,827Mark Fredric Cotton · Stellenbosch University · UM1 · FY2019 · AI
Advanced Mass Spectrometry Facility
$2,614,730David Anderson · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIC · FY2012 · DK
The National Drug Abuse Treatment Clinical Trials Network
$2,614,624Walter Nmn Ling · University Of California Los Angeles · U10 · FY2014 · DA
Regulation of hepatic and systemic immune responses
$2,610,971Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2024 · DK
Xenobiotic receptors
$2,609,568Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Hepatobiology and Toxicology COBRE
$2,608,500Craig J McClain · University Of Louisville · P20 · FY2016 · GM
PHRU-Setshaba Clinical Trials Unit
$2,607,238Glenda E Gray · Wits Health Consortium (Pty), Ltd · UM1 · FY2024 · AI
Pathogenesis, and Outcome of Autoinflammatory Diseases, NOMID/CAPS, DIRA, CANDLE, SAVI, NLRC4-MAS, Still's-like Diseases, and other Undifferentiated Autoinflammatory Diseases
$2,606,186Raphaela Goldbach-Mansky · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
UZ-UCSF CTU
$2,602,648Zvavahera Mike Chirenje · University Of California, San Francisco · UM1 · FY2016 · AI
Mechanisms and biological consequences of the nuclear receptor CAR activation
$2,598,686Masahiko Negishi · National Institute Of Environmental Health Sciences · ZIA · FY2020 · ES
Molecular Regulation Of RNA Metabolism
$2,596,317Richard J Maraia · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2024 · HD
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials Network
$2,596,126Jose Szapocznik · University Of Miami School Of Medicine · UG1 · FY2016 · DA